Russell Frank Company’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$58.1M Sell
580,323
-79,547
-12% -$8.19M 0.1% 227
2015
Q4
$79.6M Buy
659,870
+115,738
+21% +$13.4M 0.14% 161
2015
Q3
$58.8M Sell
544,132
-178,563
-25% -$22.2M 0.11% 204
2015
Q2
$83.6M Buy
722,695
+17,158
+2% +$1.96M 0.13% 167
2015
Q1
$81.3M Sell
705,537
-21,145
-3% -$2.53M 0.15% 158
2014
Q4
$82.5M Sell
726,682
-84,233
-10% -$8.88M 0.14% 167
2014
Q3
$76.9M Sell
810,915
-482,997
-37% -$43.6M 0.14% 172
2014
Q2
$113M Sell
1,293,912
-420,410
-25% -$32M 0.2% 110
2014
Q1
$120M Buy
1,714,322
+587,492
+52% +$46.5M 0.21% 109
2013
Q4
$87.6M Sell
1,126,830
-91,672
-8% -$7.25M 0.16% 144
2013
Q3
$93.8M Sell
1,218,502
-278,516
-19% -$19.5M 0.16% 135
2013
Q2
$87.5M Buy
+1,497,018
New +$90.1M 0.16% 147

Other funds holding CELG

Russell Frank Company's CELG Position: Q1 2016 in Review

Russell Frank Company reduced its Celgene Corp (CELG) stake by 12% in Q1 2016, selling an estimated $8.19M and leaving 580,323 shares worth $58.1M. The position accounts for 0.1% of the portfolio, ranked #227.

Russell Frank Company first reported a position in CELG in Q2 2013 and has held it in 12 quarters since. The position peaked at $120M in Q1 2014. 1,224 funds tracked by Wall St. Rank hold CELG as of Q1 2016.

  • Russell Frank Company held 580,323 shares of Celgene Corp worth $58.1M as of Q1 2016.
  • Russell Frank Company sold 79,547 Celgene Corp shares in Q1 2016, an estimated $8.19M.
  • Celgene Corp made up 0.1% of Russell Frank Company's portfolio in Q1 2016, its #227 holding.
  • Russell Frank Company first reported a position in Celgene Corp in Q2 2013 and has held it in 12 quarters since.
  • Russell Frank Company's Celgene Corp position peaked at $120M in Q1 2014.
  • 1,224 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.